NOTE: Click the Dual Vertical White Lines
Button, Below, to Pause; White Square Button to Stop Stream.
You need to have Windows Media Player in order to view this performance. Download it from http://www.windowsmedia.com/
Monthlies
-
Recently
- Merck (Sorta’) Opens Up — Broad “Strategic Options” Possible — Year End 2014 Completion?
- The Last Scientist-Chairman At Merck — Dr. Roy Vagelos — And His Later Endeavors: Regeneron
- Merck Paid $1.1 Billion For It In 2006 — Now Sells Sirna For $25 Million Cash, Plus $150 Million In Alnylam Stock
- Merck’s Innovation Fund Pumps $20 Million Into WellDoc — A Med App Company
- May 2013 “Interestingness” Dept.: Novartis Gave Bernstein’s Tim Anderson “A Solid No” As To The Merck Swap Rumor
- An Opportunity For The CEO To Put Some Rumors To Rest — On Monday Afternoon?
- Merck Does Another Diagnostic Oncology Test Kit Partnering/Outsourcing Deal
- The Jefferies & Co. Near Term Merck Price Target “See-Saw” Continues
Tags — Maybe Useful; Maybe Not.
$2 trillion Barack Obama Weekly Address health care reform in US Youtube video feed HD August 1 September 22 2010 $8 Million Boles II Verdict Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles June 25 2010 $473 Million IRS Shelter Abuse By Legacy Schering-Plough Under Fred Hassan 2008 2009 2010 United Health Co-Pay $60 Guidance ENHANCE Merck Cobb Polk Gradone Cain Myer ERISA Securities Derivative Schering SEAS cancer Vytorin projections July 2008 July 15 2010 2009 2013 Abbott Miles White WSJ DoJ HSR Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger October 23 2009 Additional Salmon's Asenapine Chronicles Erstwhile Salmon FDA PDAC July 30 2009 Meeting July 28 2009 Additional Salmon's Asenapine Chronicles Erstwhile Salmon FDA PDAC Phen-Fen Repeat July 31 2009 Air Hassan Carrie Cox American Air Parody Image Pharmacia Merck Payouts Manson 08-397 May 17 2009 Air Hassan Carrie Cox American Air Parody Image Pharmacia Merck Payouts Manson 08-397 September 24 2010 Amgen Prolia FDA EMEA Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles Graves Secrest Hester December 11 2010 Amgen Prolia FDA EMEA Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Keenan Boles II July 10 2010 Analysts Catherine Arnold Q3 2010 Offerings $4 billion 2009 $3.8 billion 2008 Goldman Sachs Banc of America Morgan Stanley JP Morgan Credit Suisse Bear Stearns August 3 November 11 2010 Bad for Schering Boceprivir Good for Vertex Telaprevir Bad for Schering Boceprivir Good for Vertex Telaprevir UBS Conference Hep C candidate Phase 2 Phase 3 FDA chemistry Hep C EFFICACY November 2 2009 Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 18 2009 Benadryl JNJ v. Claritin Another Battle Royale Sunscreens JNJ Neutrogena Coppertone Remicade Simponi August 6 2009 December 7 2010 Boceprevir Schering Plough Hep C Phase II Teleprevir Ph Cain v. Hassan Becherer ENHANCE stock options 2008 gran Celgene Carrie Smith Cox Pharmacia Upjohn Pfizer Largest Federal Criminal Fine Ever Searle Bextra Celebrex December 17 2009 CEO vote Becherer vote on retention by shareholders at the Annual Meeting of Shareholders in Chicago May 18 2009 Clayton Sherman Acts Temodar Wholesale Pharmacies Triple Damages For Monopoly Pricing At Risk Generics September 2009 Bloomberg March 17 April 1 September 11 2010 Cozaar Hyzaar $3.5 billion generic Singulair Teva Merck Insurers Wholesalers Antitrust Patent Invalidity Obviousness May 8 2010 Cylatron EMEA Peginterferon Alpha-2b Fail Pegintron August 24 2009 Debt deal underwriting shelf takedown red herring prospectus note deal New Merck December 7 2010 DoJ HSR Comments Second Request Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 20 2009 DoJ HSR Comments Second Request Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 21 2009 Ed Silverman InVivo Blog Remicade Simponi Sch-Merck outlicensing "change of Control" February 26 2010 Ed Silverman InVivo Blog Remicade Simponi Sch-Merck outlicensing "change of Control" September 2010 hearing date material adverse effect February 26 July 20 September 29 2010 ESC FDA SEAS Munich Germany Tuseday Dear Doctor letter FDA ODAC Pegintron October 1 2009 FEC Lobbying Reports Q3 2009 October 21 2009 Tauzin PhRMA Foradil Asthma LABA Motley Fool risk of death WSJ FDA r FTC Second Request SGP Merck Merial Intervet Animal Health Businesses HSR Required Divestitures June 22 2009 Golden Gate Pharmacy v. Pfizer Wyeth 09-3854 Merck Schering Bust Up EBITDA v. Sales Analysis August 23 2009 Graves Jury Selection Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles II Boles III October 28 2010 Hassan/Clark Schering/Merck JNJ arbitration clause Weldon bust-up JNJ Q1 2009 Call change of control Remicade Simponi August 5 2009 Health Care Reform Hearings Remarks Senate Finance Comm Herper Forbes Stein Taylor PM Gooznews SEAS Cancer Krum Ice Cream Wars at Trade Shows Trivia Hassan WhiteCoat Blog October 20 2009 In Re Vytorin/Zetia Marketing Integrilin Eptifibatide Patent Suit against generic manufacturers Millennium Teva anticompetitive February 27 2010 Invokana J and J New Drug Diabetis Type II Januvia Janumet New DrugJanuary 9 2010 February 28 June 9 2012 January 10 March 28 2013 JAMA New Study Prostate Cancer Monitor Don't Treat With Proscar Finasteride Prostate Cancer? FDA Advisory Committee December 1 2010 Krumholz Harlan Yale JAMA VIOXX Heart Attack Data Known or Knowable in 2001 through 2004 November 23 2009 Manson v. Schering-Plough Corporation Securities Fraud Merck donates $3.75 billion to river blindness initiative CEO Clark Jimmy Carter Guatemala Carter Center July 20 2009 January 24 November 11 2010 Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Maley April 23 2010 Merck Fosamax Bone Density Osteonecrosis Claims Jaw Jury Trial Deliberations Underway Intimidation US Dist Ct NY September 11 2009 Merck Fosamax Bone Density Osteonecrosis Claims Jaw US Dist Ct NY August 11 2009 Merck Merial Intervet Option to Sell Sanofi Aventis Animal Health FTC Hart Scott Divestitures Overlap Antitrust Reverse Merger July 31 2009 Merck Migranes Diabetes Apps Merck Manual Coppertone iPhone App Advertising FDA Regs December 6 September 16 2010 Merck Schering Plough COnfidential Treatment Joint Vent Merck VIOXX 2004 DoJ Criminal Grand Jury Target Letter Wells Notice March 23 2009 Merck Zostavax Vaccines problems abated biologicals uncertainty shingles vaccine June 29 2009 Michael Loucks Pfizer Schering Plough Criminal Fines Celebrex Bextra Hassan Cox Deja Vu March 20 April 2 2010 Olympics Opening Ceremonies 2008 Beijing London 2012 08 Products Liability Litigation MDL No. 1938 July 17 2008 Proscar Finasteride Prostate Cancer? FDA Advisory Committee December 1 2010 Puerto Rico Costa Rica Tax Haven Repatriation Problem Multi Billions October 27 2010 REVEAL Study DEFINE Safety Dr. Harlan Krumholz Yale Sacramento Bee Nissen Anacetrapib CV cholesterol risks 2017 2016 product FDA NDA Phase II AHA Science Sessions 2010 November 17 18 2010 Salmon July 30 2009 FDA Advisory Committee Meeting FAQs Saphris Asenapine Delay TRA delay June 10 2009 Scripps Howard Award Hip Bone Fractures Fosamax Cases NPR Osteopenia Osteoporosis December 21 2009 Fosamax March 19 2010 SEAS IMPROVE-IT Dr. Allen Taylor NEJM Heart.org FierceBiotech SEAS cancer signal letter Peto Califf Questions Schering August 17 2009 Singulair Teva Merck Insurers Wholesalers Antitrust Patent Invalidity Obviousness August 17 2009 sugammadex TheHeart.org HeartWire SHARP Vytorin End Point Redefined Clinical Trial SHARP IMRPOVE-IT 2014 October 6 November 21 2010 UnitedHealth Insurer sponsored studies Vytorin No Benefit AHA Orlando Novmeber 18 2009 USW Contract Negotiations Merck USW Local No. 10-86 West Point Durham NC PA May 10 May 12 2010 Vietnam Peginterferon Alpha-2b Fail Pegintron Saigon Bribes Commissions Penalties April 1 2010 Vioxx securities claims reinistated implications USSCT SCOTUS Argument November 30 2009 Echo of Vytorin Schering November 30 2009 Vytorin Marketing Sales Products Liability Litigation M Wellington Gates Paulson Liquidated Schering Plough Shareholdings 13G 13F August 14 2009 April 17 November 13 16 2010 WSJ DoJ HSR Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger October 15 2009Main Site [For which this Serves a Mere Back-Up!]
Archives
Categories
- $31 million Missouri AG settlement of Warrick drug pric
- 2008
- 2008 Schering stockholders' meeting snark live-blogging
- 2008 SGP EPS Share Price
- 37 Patient Seeding Study Sugammadex Bridion FDA non-app
- Abbott Copromote sell Crestor Astra Zeneca Statins gene
- above market option grants SFAS 123R compensation expen
- AIG Merrill Lehman B of A Weill Chapter 11 Bear Stearns
- AIG Merrill Lehman B of A Weill Chapter 7 Bear Stearns
- ALLEN J. TAYLOR
- AP Matt Perrone story US Health Care Reform September 8
- April 8 2008
- ARCHIVED live video and audio feeds May 14 2008 FDA Sch
- Arent Fox Let go Lowenstein Sandler hired Organon Qui T
- Arent Fox Raplon Schering Cavanaugh Qui Tam Organon Fel
- Astra USA Santa Clara Judge Raymond Fisher US Courts Su
- AstraZeneca Crestor $3B in 2008 to $8B per year by 2014
- AstraZeneca Crestor $3B in 2008 to $8B per year by 2014
- AstraZeneca Crestor $3B to $6B AHA JUPITER v. Vytorin/Z
- AstraZeneca Crestor AHA JUPITER v. Vytorin/Zetia Octobe
- Bad for Schering Boceprivir Good for Vertex Telaprevir
- Bad for Schering Boceprivir Goog for Vertex Telaprevir
- Barack Obama "Yes We Can" Video Election Day 2008
- blog stats visits statcounter maturing web-traffic Augu
- blog stats visits statcounter maturing web-traffic Spet
- Boceprevir Schering Plough Hep C Phase II Phase III Ver
- Boceprevir Schering Plough Hep C Phase II Teleprevir Ph
- Boceprevir Schering Plough Hep C Phase II Teleprevir Ph
- Bots 836000 Schering Plough Judge Dennis M. Cavanaugh o
- Brian Orelli SEAS Motley Fool Vytorin Cancer Incidence
- Brown WV
- Buffalo News Editorial: Vytorin SEAS Cancer "LINK" Sept
- Business Case for MBAs Schering: shereholder meeting Ma
- cafepharma
- CafePharma Bots ENHANCE delay $3.8 billion offering Vyt
- CafePharma discussion Vytorin scrips June 2008 IMS data
- CafePharma post moderation queue clearing July 25 2008
- Cain v. Hassan Becherer ENHANCE stock options 2008 gran
- Cain v. Hassan Becherer ENHANCE stock options 2008 gran
- Cain v. Hassan Becherer ENHANCE stock options 2008 gran
- Cain v. Hassan Securities Mason 08-397 Derivative Suit
- Case No. 3:08-cv-01974 (US Dist Ct NJ
- cash-flow
- CEO Compensation 2007 Proxy $30.32 million v. 29.6 mill
- CEO Compensation Survey Becherer Nominating committee C
- CEO Hassan's Russian Folly Can't Save Christmas Bonus 2
- Clarinex 2002 Old ERISA Class Action Suit Certified Zho
- Clarinex Descloratadine Patent Litigation (MDL No. 1851
- Clarinex Descloratadine Patent Litigation (MDL No. 1851
- Claritin Bejing Olympics Deal Telepravir Vertex Scherin
- class actions Oettinger Schering conflict interest Bech
- CNBC Schering-Plough puff piece August 20 2008
- Cobb
- Compensation Committee Hans Becherer consultant Ira T.
- Compensation Committee Hans Becherer consultant Ira T.
- Complaint filed April 21
- Complaint originally filed January 18
- Constitutional law first amendment video House Rule XI
- Converts due 2010 6 percent preferred price pharma like
- Conyers Judiciary Universal Health care people of color
- Cordaptive Schering Merck Vytorin Zetia April 22 2008
- Corp Fin SEC 8-K Choleserol fanchise Vytorin Vetia rang
- Covington and Burling DC law firm Richard Kingham partn
- Covington and Burling RNC lawyers Schering-Plough couns
- Cramer Mad Money Boceprevir Schering Plough Hep C Phase
- Cramer Mad Money Mailbag Schlock Journalism September 1
- credit crunch
- Credit Suisse Analysis $32 independent?
- Crestor Astra Zeneca Statins generics Herper Forbes Sch
- Crestor Astra Zeneca Statins generics Schering Plough V
- debt service
- Dechert LLP Vytorin ENHANCE SEAS Stein Email Fallout li
- Dennis Quaid FDA Preemption Hearing preliminary Transcr
- Dezenhall Washington DC Communications Consultants Dama
- Dingell
- Dingell Stupak August 21 2008 SEAS cancer letter Peto Q
- doctordavidsblog SEAS ENHANCE Cancer Vytorin Zetia Sept
- DOJ
- DoJ AUSA Robert Kirsch Investigations ENHANCE Vytoirn Z
- Dr. Bots ENHANCE November 2007 Covington and Burling DC
- Dr. John Kastelein SPRI Christensen Soren Bo Veltri Enr
- Drug Stock Short Stories Joseph Hargett Forbes Schering
- DTC
- DTC Canada Nasonex Vytorin Zetia Quebec Rueters Septemb
- Easterbrook Merck Cobb ERISA conflict of interest insid
- Easterbrook Oettinger
- Ed Silverman PM Gooznews PharmaGossip Peter Rost Nissen
- Eli Lilly Co. Merck Co. Schering-Plough Sen. Chuck Cha
- ENHANCE consumer fraud MDL 1938 Dechert LLP Schering Me
- ENHANCE consumer fraud MDL 1938 Dechert LLP Schering Me
- ENHANCE functional unblinding Realizations in BioStatis
- ENHANCE November 2007 Covington and Burling DC law firm
- ENHANCE Sen. Charles Chuck Grassley January 2007 Unblin
- ENHANCE Sen. Charles Chuck Grassley January 2007 Unblin
- ENHANCE Sen. Charles Chuck Grassley January 2007 Unblin
- ERISA Claims class actions Cobb Oettinger Schering Merc
- ESC FDA SEAS Munich Germany Tuseday Dear Doctor letter
- et al.
- et al. (Case No. 08-397
- et al. shareholders derivative action Schering June 4 2
- et al. v. Merck Judge ERISA Dennis M. Cavanaugh Brown G
- et al. v. Schering-Plough Corp. Merck Cobb ERISA confli
- EU DTC Parma distain direct communication v. adverts ju
- fall off
- Faux Brand Name Drug Ad Vytorinoxil parody by Holton Se
- FDA Device Modernization Act DTC Advertising House Comm
- FDA Device Modernization Act House Committee Hearing Ma
- FDA Joan Hankin Vytorin misleading product promotional
- FDA Preemption Case SCOTUS Roberts Breyer Pharmalot May
- FDA SEAS Dear Doctor letter Label-Copy Misbranded Drugs
- FDA Wall Street Journal Online Schering Plough NDA ANDA
- FEC.gov Schering-Plough PAC Committee Barton Burgess Sh
- Federal Reserve Board Chairman Ben Bernake June 16 2008
- Feldstein Organon Raplon 2001 1999 2005 Schering crimin
- Feldstein Organon Raplon Case No. 07-2690 DMC 2001 1999
- Forbers Herper Matt Fleming Thomas SEAS cancer Vytorin
- Form 10-Q Criminal US Attorneys investigations requests
- Form 8-K Scrips data Vytorin Zetia Cholesterol Manageme
- Fred Hassan CEO media hype SGP ENHANCE debacle $1.5 bil
- from Vytorin Zetia
- GAO Deficit Senate Finance Grassley Baucus Health Care
- Genzyme Schering ENHANCE mipomersen surrogate endpoints
- gesundheit.blogger.de Vytorin Inegy SEAS Germany linked
- Glaxo Novartis CEO Witty Andrew Fred Hassan Schering FD
- Goldman Sachs and Co. Arent Fox JP Morgan Securities I
- Goldman Sachs BHC Fed Reserve Glass Stegal Graham Pfize
- Gradone Sabatella class actions Oettinger Schering conf
- Gradone v. Schering ERISA Class Action Filed March 13 2
- graphics logos creative commons copy left 2008
- Grassley Baucus Hearing Senate Finance Committee Health
- Grassley Dingell Stupak COngressional investigations Sc
- Grassley Hassan CEO Schering Plough Vytorin Zetia ENHAN
- Grassley Medicare Medicaid reform non and not for profi
- Grassley Sabatino SGP Schering Sunshine Cardioloists le
- Grassley Stupak Dingell Schering Merck August September
- Grassley Thorton FDA Surrogate Endpoints Outcomes Studi
- Guess the Compound Trivial Pursuit August 7 2008
- Hard Net Assets Per Share Value Foreign Currency Exchan
- Hassan $2 million stock april 24 2008 january 18 2008 E
- Hassan 836000 stock options $18.85 20 percent performan
- HASSAN BECHERER COLLIGAN KIDDER LEDER MCGRATH MUNDY PER
- Hassan Becherer Schering job cuts Organaon ENHANCE $1.5
- Hassan Claritin Clarinex Vytorin Zetia 2002 v. 2008 tru
- Hassan compensation 2006 2007 2008 performance measures
- Hassan Compensation 2007 stock purchase $2 million ENHA
- Hassan ENHANCE SANDS Clark Dick Vagelos Roy Merck comm
- Hassan predicts Schering's "Russian growth" Farce CNBC
- Hassan Q1 Conference Call Schering Vytorin Zetia Organo
- HCC UK Health Care Channel flash video January 31 2008
- Health Care Reform Hearings 2008 elections cycle Dingel
- Health Care Reform Hearings and Summit Remarks Senate F
- Health Care Reform Hearings Bertko Rand Humana Insuranc
- Health Care Reform Hearings Remarks Senate Finance Comm
- Health Care Reform Senator Chuck Grassley Max Baucus He
- Health Care Summit June 16 2008
- Hearing
- Herper Forbes CASHMERE lipitor Enhance Vytorin Zetia Sc
- Herper Forbes Stein Taylor PM Gooznews SEAS Cancer Krum
- Herper Forbes VYCTOR ClinicalTrials.gov Merck Schering
- Herper Silverman PM Gooznews Nissen Enrico Veltri CafeP
- House NIH Reform Act 2006 DIngell Stupak September 9 20
- Hytorin antezetimbe faux drug parody spoof humor LDL ca
- Illinois State Medicaid Drops Vytorin as of July 1 2008
- IMPROVE-It 2012 Vytorin FDA to require outcomes data fo
- IMS August 2008 Post SEAS Downturn scrips Vytorin Zetia
- IMS Data PharmaKing April 14 2008 for Week of April 4 2
- IMS Monthly data Vytorin Zetia Hassan Updated Investor
- IMS Scrips data Vytorin Zetia July June 2008 Form 8-K A
- In Re Vytorin/Zetia Marketing
- insider trading question cafepharma schering plough cox
- Ira Kay Hans Bechereer Schering Compensation Committee
- Jack Hough Glaxo buyout Schering Overpriced November 6
- Jarvik
- Jet and Driver Schering Plough commuters April 24 2008
- John McCain Vytorin Zocor ENHANCE market share erosion
- John McCain Vytorin Zocor ENHANCE market share erosion
- joint venture
- JP Morgan $28 SGP Analyst independent?
- JP Morgan Franchise 16 recession-proof stocks Schering
- JP Morgan Microsoft NuCor A T and T Schering Plough "up
- JP Morgan Schering analysis tainted by bias? upgrade Ju
- Jr. May 20 2008 proxy nondisclosures
- Judge Frank Easterbrook Seventh Circuit ERISA decision
- Judge Jack Weinstein RICO Overcharging Excessive Utilit
- Kaiser CEO Testimony George C. Halvorson Senate Finance
- Kansas fraud pharma deliberate overcharging Medicare Me
- King Pharmaceuticals CEO top 25 Overpaid Glass Lewis Sc
- krumholz NEJM Zetia trends 2002 2006 No Advertising Can
- Krumholz NEJM Zetia trends Munich Germany ESC US script
- Lehman Barclays Capital Schering ENHANCE Hassan October
- Lehman Brothers Holdings Crisis in the Markets Septembe
- light blogging forecasted for April 28 to 30 2008
- Lipitor
- Low Quality in Health Care The Necessity for Reform Sen
- Low Quality in Health Care The Necessity for Reform Sen
- Low Quality in Health Care The Necessity for Reform Sen
- Lowenstein Sandler PC Mayer Brown LLP Schering Plough J
- Manson v. Schering-Plough Corporation
- Manson v. Schering-Plough Corporation Securities Fraud
- Manson v. Schering-Plough Corporation Securities Fraud
- Manson v. Schering-Plough Corporation Securities Fraud
- Manson v. Schering-Plough Corporation Securities Fraud
- Marketing
- Matt Herper Forbes Sugammadex Bridion FDA non-approvabl
- May 8 2008
- may 9 2008
- McCarter and English Latham and Watkins Schering Plough
- MD Department of Medicine Cardiology Walter Reed Army M
- MDL Consumer Fraud Marketing Fraud Dechert LLP Schering
- Medicare appeal process reform letter HHS Secretary Gra
- Medicare Improvements Act Finance Senators Baucus Grass
- Merck
- MERCK CLARK HASSAN vytorin zetia $700 to $900 million E
- Merck Dick Clark Q3 Earnings Conference Call October 22
- Merck Form 10-Q disclosures September 30 2008 Novemebr
- Merck Richard Clark Merck First Quarter Q1 2008 earning
- Merck Schering Plough COnfidential Treatment Joint Vent
- Merck Schering Plough Confidential Treatment Joint Vent
- Merck Schering Plough Confidential Treatment Joint Vent
- Merck Schering Q2 Form 10-Q SEC Hassan Clark JV Termina
- Merck Schering Q2 Press Release Hassan Clark JV Termina
- Merck Schering Q3 2008 Conference Call Blogging SEC Has
- Merck Schering Vytorin SEAS cancer statin/ezetimibe v.
- Merck Vytorin Zetia Securitites Fraud Class Action Cons
- Merrill Lynch
- Merrill Lynch August 2007 Offering $27.50 v. $18 v. $17
- Mike Huckman CNBC Levitra Schering ED Viagra July 16 20
- Morgan Stanley Fred Hassan schering Q1 false Form 8-K I
- NASA VIDEO FEED Phoenix Mars lander ice life extraterre
- New Haven Connecticut Vytorin MDL 1938 Case No.08-285 P
- New York State Medicaid Drops Vytorin as of October 1 2
- New York Times SEAS Cancer Editorial Vytorin Zetia non-
- New York Times SEAS Cancer Vytorin Zetia non-effective?
- Nissen PM Gooznews cancer LDL too low Pharmalot DeMaria
- Obama Biden WSJ Health care reform USA 2009 August 22 2
- Obama McCain NYT September 12 2008 Health Care Reform S
- Oettinger Gradone Sabatella ERISA ENHANCE Case Order in
- Off topic Gustav NOAA GOES Satellite Category 4 New Orl
- Off Topic Sand Castle August 2008 Master Builders
- Olympics Opening Ceremonies 2008 Beijing London 2012 08
- Orchid Merck Joint development deal Patent Suit Clarine
- Organon Qui Tam FCA Update Lowenstein Sandler Arent Fox
- Organon Qui Tam update Lowenstein Sandler Arent Fox Jef
- Patent No. 274 In Re Descloratadine Patent Litigation (
- Paul Hodgson Matt Herper Forbes Becherer Hassan above m
- Peter Lee testimonty before Senate Finance Committee He
- Pfizer
- Pfizer Lipitor Astra Zeneca Crestor v. Vytorin/Zetia En
- Pharmaceutical industry IP Senate hearing Baucus Grassl
- Pharmagossip Insider Bob Redford Three days of the Cond
- Pharmalot
- Pharmalot Vytorin Zetia Schering Plough fall off income
- Physicians Payments Sunshine Act legislation support le
- Physicians Payments Sunshine Act legislation support le
- Pipeline
- PM Goozenews Reveal Children on Statins or Schering's V
- PM Gooznews cancer LDL too low Pharmalot DeMaria Ben-Ye
- PM Gooznews cancer SEAS Vytorin Zetia plant sterols Aug
- PM Gooznews SEAS Cancer Krumholz Yale Vytorin Third Lin
- PM Gooznews SEAS Cancer Vytorin Peto NEJM September 5 2
- Poll Health care reform politics US cover or not? Septe
- Poses Brown and Raggi [Harrison DG
- Price Fraud Medicare Medicaid Texas Missouri penalty $7
- probe
- Products Liability Litigation MDL No. 1938 July 17 2008
- Products Liability Litigation MDL No. 1938 July 17 2008
- Q3 2008 SEC Form 10-Q omission decline Vytorin ENHANCE
- Q3 2008 SEC Form 10-Q truth-telling no omissions contin
- Raggi P. Enhance. Am J Cardiol 2008; 102: 368-369 Augus
- Raplon Dennis Cavanaugh Mark Falk Schering Organon Feld
- Raplon Organon Dr. Feldstein Schering criminal matter Q
- Raplon Schering Organon criminal inquiry due diligence
- Reform Senator Chuck Grassley Hearing 47 Million and Co
- Reform Senator Chuck Grassley Max Baucus June 6 2008 He
- Reform Senator Chuck GrassleySenator Max Baucus 47 Mill
- Reform Senator Chuck GrassleySenator Max Baucus 47 Mill
- Rep Stupak FDA "Misleading" DTC Advertising Deepak Khan
- Reuters Dr Heinz Drexel University of Innsbruck Austri
- Richard Peto report PDF SEAS Vytorin Cancer Incidence F
- RICO Suit Class action February 7
- Russian Folly Can't Save Christmas Bonus 2008 October 7
- Sales Marketing Vytorin Zetia Products Liability Litiga
- Sales Practices
- Sales Practices and Products Liability Cases order Lead
- Sales Practices and Products Liability Class Action Con
- Sales Practices and Products Liability Litigation (MDL
- Salmon Teleprevir VX-950 Boceprivir similar compounds H
- Salmon's analysis of psychopharmacologic Asenapine schi
- Salmon's analysis of psychopharmacologic Asenapine schi
- Salmon's analysis of psychopharmacologic Asenapine schi
- Sandoz Clarinex Descloratadine patent Clarinex RediTabs
- Sandoz Clarinex patent Nos. 274 463 declaratory judgmen
- Say on Pay Becherer Hans Hassan CEO Cain v. Hassan ERIS
- Schering
- Schering 2009 Vytorin Planner Hassan October 29 2008
- Schering Boceprevir Vertex Telaprevir JNJ candidate Pha
- Schering Boceprevir Vertex Telaprevir JNJ drug Hep C ca
- Schering Boceprevir Vertex Telaprevir JNJ drug Hep C ca
- Schering Boceprivir Vertex Telaprevir Morgan Stanley Un
- Schering Boceprivir Vertex Telaprevir Morgan Stanley Un
- Schering Clarinex Latham Watkins Claritin Descloratadin
- Schering DTC Hassan Dingell Stupak Advertising FDA Drug
- Schering Enhance Bos Stony Vytorin Zetia Congress FDA m
- Schering et al. Case 08-3711 indictable RICO pattern ra
- Schering foreign currency reversals NYT Q4 euro falls m
- Schering generic threats FDA non-approvable letter Apri
- Schering Merck Joint Venture loratadine montelukast com
- Schering Merck Vytorin Zetia ENHANCE litigation EPS gue
- Schering Organon acquisition November 2007 October 16 2
- Schering PAC Hassan FEC Giving records in 2008 Bailout
- Schering Plough Judge Dennis M. Cavanaugh on Cain v. Ha
- Schering Plough securities class action Kastelein Bots
- Schering Plough securities class action Kavanaugh LEAD
- Schering Plough securities fraud litigation Cavanaugh F
- Schering Plough Vytorin Zetia SGP Securities Fraud Laws
- Schering psychopharmacologic Asenapine schizophrenia EU
- Schering Q2 SEAS Vytorin fallout lost profits of $1 bil
- Schering Q3 Earnings conference call October 21 2008
- Schering stock price ankylosing spondylitis indication
- Schering-Plough
- SEAS Cancer Dear Doctor letter FDA Labeling Warning Is
- SEAS Cancer finding rigorous review Krumholz Harlan Yal
- SEAS cancer Vyotrin DoD database TRICARE McGinnis Thera
- SEAS Munich Herper Vytorin Nissen Cleveland ENHANCE Sep
- SEAS Schering Merck Vytorin "Update" Terje Pedersen Chi
- SEAS Schering Vytorin Zetia NYSE trading halts listed c
- SEAS study failure material event Q2 Earnings Release N
- SEAS Vytorin Cancer Incidence Secret FDA Report Peto St
- SEAS Vytorin Cancer Peto Richard FDA Dingell Krumholz S
- SEC Form 10-Q truth-telling no omissions continued decl
- SEC Timeline Outlier Data ENHANCE January 2007
- Senate Finance Committee Chair Rising Costs
- Senate Finance Committee Chair Rising Costs June 9 2008
- SGP Gross Margins on all other Products ex-Vytorin/Zeti
- SGP Offerings Notes Stock Converts $3.8 billion 3 billi
- SGP PB 6% perferred August 2010 capital loss ordinary i
- SGP SEC claims MDL Arkansas Teacher Public Employees’
- shareholder derivative action US Dist Ct NJ Amended Com
- shareholder derivative action US Dist Ct NJ Amended Com
- shareholder derivative action US Dist Ct NJ Amended Com
- Shearman and Sterling LLP Sills Cummis and Gross Scheri
- stalling out
- story
- Stupak
- Stupak Dingell AP Johnson Hassan FDA Vytorin SEAS cance
- Stupak Dingell James Stein MD University of Wisconsin M
- Stupak DTC Deepak Khanna Joint Venture Merck Pharma Vyt
- Suffolk County v. Schering
- sugammadex EU approval 2.4 cents 2008 EPS not enough Br
- sugammadex EU approval 2.4 cents 2008 EPS not enough Br
- Susan Ellen Wolf 2005 proxy statment market cap metric
- Telapravir v. Boceprevir Schering Plough Hep C Phase II
- Teleprevir VX-950 Boceprivir Hepatitis C next generatio
- Three Days of the Condor Identity Logo
- Tommy Thompson health care reform September 17 2008
- Uncategorized
- US Dist. Ct. NJ) before Judge Cavanaugh ENHANCE August
- US Health Care Cost Reform Remarks Senate Finance Commi
- US market Vytorin Zetia falloff through 8 months in 200
- Van Pools Hassan Private Car
- Vertex Johnson and Johnson Hep C Hepatitis June 9 2008
- Vicriviroc Schering Phase III HIV drug candidate study
- VIDEO FEED of Dennis Quaid FDA Preemption Hearing preli
- Vioxx securities claims reinistated implications for Vy
- Vytorin Bounced in Europe for Kids EMEA Children Spared
- Vytorin INCOME off close to $900 million still losing s
- Vytorin J/V INCOME off close to $900 million still losi
- Vytorin James Stein MD ENHANCE RICO Pattern Activities
- Vytorin Marketing
- Vytorin Marketing Sales Products Liability Litigation M
- Vytorin MDL 1938 Case No.08-285 Polk Schering consumer
- Vytorin Sales fall off Hide the Ball April 2008 Monthly
- Vytorin Sales fall off Hide the Ball April 2008 Monthly
- Vytorin Sales off still losing share May 2008 Monthly f
- Vytorin Schering Hassan CEO Statements Media Press Over
- Vytorin science not proven RICO Complaint
- Vytorin SEAS statin/ezetimibe v. placebo trial FDA proc
- Vytorin study Merck clinicaltrials.gov Audust 18 2008 V
- Vytorin Zetia Ad revisions FDA April 24 2008 a little l
- Vytorin Zetia doesn't work how know 4X cost
- Vytorin Zetia market falloff US prescriptions zocor McC
- Vytorin Zetia Sales Marketing and Products Liability Li
- Vytorin Zetia Scrips August 2008 6 percent share declin
- Vytorin Zetia Scrips June 2008 26.6 percent decline shr
- WBB Securities Steve Brozak NEJM SEAS Cancer September
- William C. Weldon Johnson and Johnson Hassan CEO Scheri
- WSJ
- WSJ IMS Scrips decline 2008 Q2 v Q1 Vytorin Zetia marke
- WSJ J.P. Morgan Chase
- WSJ Video Pfizer Lipitor Astra Zeneca Crestor v. Vytori
- WSJ Vytorin Schering June 17 2008 Pharmalot 6 months v.
- Wyeth v Levine Pharmalot USSCT November 3 2008 oral arg
shearlingsplowed.wordpress.com 